NCT06212427View on ClinicalTrials.gov

Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)

NARecruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Premature InfantLow Birthweight Infant
Interventions
DIETARY_SUPPLEMENT

HMO supplement

Liquid supplement containing 2 specific HMOs. Supplement will be given 3-4 times a day, not mixed with any feeding.

Trial Locations (6)

4020

RECRUITING

Kepler Universitätsklinikum Linz, Linz

90419

RECRUITING

Klinikum Nürnberg, Nuremberg

Unknown

RECRUITING

Evangelisches Waldkrankenhaus Spandau, Berlin-Spandau

RECRUITING

Kinderklinik Darmstadt, Darmstadt

WITHDRAWN

Wilhelmstift Hamburg, Hamburg

RECRUITING

Uniklinik Heidelberg, Heidelberg

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY